FXR/SHP plays a role in NAFLD protection by regulating lipid homeostasis and anti-inflammation (Fiorucci et al., 2004; Watanabe et al., 2004; Carr and Reid, 2015). Here, NR0B2 is linked to metabolic dysfunction-associated steatotic liver disease.